Myelopreservation results; the objective response rate, or ORR; progression-free survival, or PFS; and safety data were presented at the San Antonio ...
News
- What's Behind The Rally In Small-Cap Biotech G1 Therapeutics?
- Amazon Aims to Launch Booze Delivery Services in San Francisco
... the likes of Austin, Dallas-Fort Worth, Houston and San Antonio last year. ... The biotech sector is projected to surge beyond $775 billion by 2024 as ... Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now ...
- Texas Biomed Will Study Drugs To Fight Aging
San Antonio researchers will experiment with older baboons to see if new drugs can help ease the challenges that come with getting older. Scientists ...
- MoneyGram surges and Nvidia rallies while Facebook slips
Pacific Biosciences of California Inc., down 28 cents to $6.40. The genetic analysis technology company is facing a potential regulatory hurdle in ...
- What's Propelling Syros Pharmaceuticals, Inc. (SYRS) to Increase So Much?
... Nasdaq.com which released: “These 3 Biotech Stocks Are Now On My Watchlist – Nasdaq” on October 03, 2018, ... titled: “Syros Announces New Preclinical Data on SY-1365 at San Antonio Breast Cancer Symposium – Business ...